ATE346295T1 - Synthetische verbindungen mit zwei epitopen für immunoassays - Google Patents

Synthetische verbindungen mit zwei epitopen für immunoassays

Info

Publication number
ATE346295T1
ATE346295T1 AT00958689T AT00958689T ATE346295T1 AT E346295 T1 ATE346295 T1 AT E346295T1 AT 00958689 T AT00958689 T AT 00958689T AT 00958689 T AT00958689 T AT 00958689T AT E346295 T1 ATE346295 T1 AT E346295T1
Authority
AT
Austria
Prior art keywords
immunoassays
epitopes
synthetic compounds
advantageously
carrier molecule
Prior art date
Application number
AT00958689T
Other languages
English (en)
Inventor
Isabelle Nathalie Garric
Isabelle Karine Giuliani
Catherine Christiane Mar Larue
Francois Yves Rieunier
Sylvie Marie-France Trinquier
Original Assignee
Bio Rad Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur filed Critical Bio Rad Pasteur
Application granted granted Critical
Publication of ATE346295T1 publication Critical patent/ATE346295T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00958689T 1999-08-16 2000-08-14 Synthetische verbindungen mit zwei epitopen für immunoassays ATE346295T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910526A FR2797689B1 (fr) 1999-08-16 1999-08-16 Utilisation de composes synthetiques pour des immunodosages

Publications (1)

Publication Number Publication Date
ATE346295T1 true ATE346295T1 (de) 2006-12-15

Family

ID=9549166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958689T ATE346295T1 (de) 1999-08-16 2000-08-14 Synthetische verbindungen mit zwei epitopen für immunoassays

Country Status (9)

Country Link
US (1) US8013115B1 (de)
EP (1) EP1204865B1 (de)
JP (1) JP4447811B2 (de)
AT (1) ATE346295T1 (de)
CA (1) CA2382035C (de)
DE (1) DE60031990T2 (de)
ES (1) ES2275542T3 (de)
FR (1) FR2797689B1 (de)
WO (1) WO2001013114A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
CA2441228A1 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
EP1497314A4 (de) * 2001-09-07 2007-10-10 Univ Texas Auf peptide gegen plazenta- und fettgewebe abzielende zusammensetzungen und verwendungsverfahren
CA2475456A1 (en) 2004-07-20 2006-01-20 Biophys, Inc. Method and device to optimize analyte and antibody substrate binding by least energy adsorption
EP2567974A3 (de) 2004-09-22 2013-05-22 Cancer Advances, Inc., Monoklonale Antikörper gegen Progastrin
US8920628B2 (en) 2012-11-02 2014-12-30 Roche Diagnostics Operations, Inc. Systems and methods for multiple analyte analysis
KR20170095364A (ko) * 2014-12-18 2017-08-22 비오메리으 합성 이중-에피토프 화합물
IL271427B2 (en) 2017-06-15 2025-08-01 Cancer Advances Inc Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
WO2024243119A2 (en) * 2023-05-19 2024-11-28 Spectrum Solutions L.L.C. Products and methods for preserving and detecting biomolecules in human saliva samples

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106834A (en) * 1988-12-27 1992-04-21 G. D. Searle & Co. Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
EP0552247A1 (de) 1990-10-10 1993-07-28 The Upjohn Company Peptide mit substituierten 1,4-diaminen als übergangszustandeinschub
CA2089747A1 (en) * 1990-10-11 1992-04-12 Gerd Schnorrenberg Cyclopeptides, a method of preparing them, and their use as drugs
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
DE19524572A1 (de) * 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
AU4981897A (en) * 1996-10-15 1998-05-11 Navix, Inc. Stabilized conjugates of uncomplexed subunits of multimeric proteins
FR2756827B1 (fr) * 1996-12-05 1999-01-29 Pasteur Sanofi Diagnostics Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i

Also Published As

Publication number Publication date
FR2797689B1 (fr) 2003-06-27
DE60031990T2 (de) 2007-06-06
JP4447811B2 (ja) 2010-04-07
FR2797689A1 (fr) 2001-02-23
DE60031990D1 (de) 2007-01-04
WO2001013114A1 (fr) 2001-02-22
EP1204865B1 (de) 2006-11-22
JP2003507711A (ja) 2003-02-25
US8013115B1 (en) 2011-09-06
EP1204865A1 (de) 2002-05-15
CA2382035C (fr) 2012-10-09
CA2382035A1 (fr) 2001-02-22
ES2275542T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
DE60031990D1 (de) Synthetische verbindungen mit zwei epitopen für immunoassays
CA2265484A1 (en) Tumor homing molecules, conjugates derived therefrom, and methods of using same
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
AU3944401A (en) Improvements to ribosome display
DK0404097T3 (de)
ATE93628T1 (de) Peridinin-chlorophyll-komplex als fluoreszierende erkennungszeichen.
EP2338915A3 (de) Anti-VEGF Antikörper
BR0011849A (pt) Anticorpos enxertados lm609 melhorados
CY1105087T1 (el) Νεες αντιβακτηριακες ουσιες
EP0728215A4 (de) METHODE ZUR BINDUNG VON MATERIAL AN DAS -g(b)-AMYLOID-PEPTID
DE69829891D1 (de) Anti-VEGF Antikörper
GB9824632D0 (en) Biological compounds
CA2178642A1 (en) Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
AU8814191A (en) Cell-free receptor binding assays, the production and use thereof
BR0116686A (pt) Anticorpos anti-cd28 silenciados e uso dos mesmos
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE69942668D1 (de) Humanisierter monoklonaler antikörper gegen von-willebrand faktor
IL140413A0 (en) A complex of an enzyme, a protein and a carrier
ATE217086T1 (de) Herstellung von photoprotein konjugaten und verfahren zu ihrer verwendung
DE59800519D1 (de) Immunoassay zur Aviditätsbestimmung von Immunglobulinen
ATE420183T1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
AU2001292118A1 (en) Dye-labelled peptide and its diagnostic use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties